Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Nov 30, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 1.2M | 675,000 | 585,000 | 435,000 | 745,000 |
| General And Administrative Expense | 1.2M | 675,000 | 585,000 | 435,000 | 745,000 |
| Other Operating Expenses | 71,000 | 72,000 | 33,000 | 76,000 | 33,000 |
| Operating Expense | 1.3M | 747,000 | 618,000 | 511,000 | 778,000 |
| Operating Income | -1.3M | -747,000 | -618,000 | -511,000 | -778,000 |
| EBIT | -3.9M | -675,000 | -615,000 | -445,000 | -959,000 |
| Interest Expense | 13,000 | 5,000 | 3,000 | 3,000 | -- |
| Interest Expense Non Operating | 13,000 | 5,000 | 3,000 | 3,000 | -- |
| Net Interest Income | -13,000 | -5,000 | -3,000 | -3,000 | -4,000 |
| Other Income Expense | -2.6M | 72,000 | 3,000 | 66,000 | -1.8M |
| Other Non Operating Income Expenses | 4,000 | 1,000 | 13,000 | 38,000 | 16,000 |
| Gain On Sale Of Security | -2.6M | 71,000 | -10,000 | 28,000 | 15,000 |
| Pretax Income | -3.9M | -680,000 | -618,000 | -448,000 | -2.6M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| Net Income From Continuing Operation Net Minority Interest | -3.9M | -680,000 | -618,000 | -448,000 | -2.6M |
| Net Income Including Noncontrolling Interests | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| Net Income Common Stockholders | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| Net Income | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| EBITDA | -3.9M | -669,000 | -610,000 | -440,000 | -950,000 |
| Normalized EBITDA | -1.3M | -740,000 | -600,000 | -468,000 | 876,000 |
| Reconciled Depreciation | 5,000 | 6,000 | 5,000 | 5,000 | 9,000 |
| Basic EPS | -0.01 | 0.00 | 0.01 | 0.00 | -- |
| Diluted EPS | -0.01 | 0.00 | 0.01 | 0.00 | -- |
| Basic Average Shares | 365.4M | 256.3M | 225.7M | 193.2M | -- |
| Diluted Average Shares | 365.4M | 256.3M | 225.7M | 193.2M | -- |
| Total Unusual Items | -2.6M | 71,000 | -10,000 | 28,000 | -1.8M |
| Total Unusual Items Excluding Goodwill | -2.6M | 71,000 | -10,000 | 28,000 | -1.8M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.3M | -751,000 | -608,000 | -476,000 | -766,000 |
| Diluted NI Availto Com Stockholders | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| Net Income Continuous Operations | -3.9M | -680,000 | -618,000 | -448,000 | -2.6M |
| Net Income Discontinuous Operations | 49,000 | -95,000 | 2.8M | 169,000 | 539,000 |
| Net Non Operating Interest Income Expense | -13,000 | -5,000 | -3,000 | -3,000 | -4,000 |
| Other Gand A | 597,000 | 471,000 | 478,000 | 435,000 | 745,000 |
| Salaries And Wages | 633,000 | 204,000 | 107,000 | -- | -- |
| Total Expenses | 1.3M | 747,000 | 618,000 | 511,000 | 778,000 |
| Line Item | Q4 2025Nov 30, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 16.3M | 2.4M | 945,000 | 710,000 | 1.3M |
| Cash Cash Equivalents And Short Term Investments | 16.3M | 2.4M | 945,000 | 710,000 | 1.3M |
| Cash Financial | 16.3M | 2.4M | 945,000 | 710,000 | 1.3M |
| Accounts Receivable | 388,000 | -- | -- | -- | -- |
| Receivables | 558,000 | 237,000 | 293,000 | 192,000 | 181,000 |
| Prepaid Assets | 98,000 | 98,000 | 98,000 | 98,000 | 98,000 |
| Current Assets | 17.0M | 2.8M | 1.5M | 1.2M | 1.8M |
| Gross PPE | 6.8M | 6.8M | 6.2M | 3.4M | 3.6M |
| Accumulated Depreciation | -121,000 | -77,000 | -80,000 | -87,000 | -73,000 |
| Net PPE | 6.6M | 6.7M | 6.1M | 3.3M | 3.5M |
| Total Non Current Assets | 6.6M | 6.7M | 6.1M | 3.3M | 3.5M |
| Total Assets | 23.6M | 9.5M | 7.6M | 4.5M | 5.4M |
| Current Debt And Capital Lease Obligation | -- | -- | 27,000 | -- | -- |
| Accounts Payable | 818,000 | 526,000 | 665,000 | 426,000 | 443,000 |
| Payables | 818,000 | 526,000 | 665,000 | 426,000 | 443,000 |
| Payables And Accrued Expenses | 820,000 | 528,000 | 667,000 | 428,000 | 445,000 |
| Current Accrued Expenses | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Other Current Liabilities | 4.1M | 10.6M | 10.6M | 13.4M | 13.6M |
| Current Liabilities | 4.9M | 11.1M | 11.3M | 13.8M | 14.0M |
| Long Term Debt And Capital Lease Obligation | -- | -- | 147,000 | -- | -- |
| Long Term Capital Lease Obligation | -- | -- | 147,000 | -- | -- |
| Other Non Current Liabilities | -- | 2.6M | 2.6M | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 2.6M | 2.7M | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 4.9M | 13.7M | 14.0M | 13.8M | 14.0M |
| Common Stock | 90.7M | 72.3M | 70.1M | 69.5M | 69.5M |
| Capital Stock | 90.7M | 72.3M | 70.1M | 69.5M | 69.5M |
| Retained Earnings | -81.8M | -86.1M | -85.3M | -87.5M | -87.2M |
| Gains Losses Not Affecting Retained Earnings | -1.4M | -2.2M | -2.5M | -2.2M | -1.8M |
| Common Stock Equity | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Stockholders Equity | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Total Equity Gross Minority Interest | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Minority Interest | 6,000 | -9,000 | -9,000 | -6,000 | -6,000 |
| Total Capitalization | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Net Tangible Assets | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Tangible Book Value | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Working Capital | 12.1M | -8.3M | -9.8M | -12.6M | -12.2M |
| Invested Capital | 18.7M | -4.2M | -6.4M | -9.3M | -8.6M |
| Total Debt | -- | -- | 174,000 | -- | -- |
| Share Issued | 392.0M | 275.0M | 235.6M | 205.6M | 205.6M |
| Ordinary Shares Number | 392.0M | 275.0M | 235.6M | 205.6M | 205.6M |
| Assets Held For Sale Current | 10,000 | 90,000 | 192,000 | 210,000 | 226,000 |
| Capital Lease Obligations | -- | -- | 174,000 | -- | -- |
| Current Capital Lease Obligation | -- | -- | 27,000 | -- | -- |
| Foreign Currency Translation Adjustments | -1.4M | -2.2M | -2.5M | -2.2M | -1.8M |
| Other Equity Interest | 11.2M | 11.8M | 11.3M | 10.8M | 10.8M |
| Other Properties | 6.8M | 6.8M | 6.2M | 3.4M | 3.6M |
| Other Receivables | -- | 122,000 | 182,000 | 89,000 | 106,000 |
| Restricted Cash | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 |
| Taxes Receivable | 170,000 | 115,000 | 111,000 | 103,000 | 75,000 |
| Line Item | Q4 2025Nov 30, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -733,000 | -674,000 | -551,000 | -546,000 | -604,000 |
| Cash Flow From Continuing Operating Activities | -733,000 | -674,000 | -551,000 | -546,000 | -604,000 |
| Depreciation And Amortization | 5,000 | 6,000 | 5,000 | 5,000 | 9,000 |
| Depreciation Amortization Depletion | 5,000 | 6,000 | 5,000 | 5,000 | 9,000 |
| Stock Based Compensation | 633,000 | 204,000 | -- | -- | -- |
| Change In Working Capital | -58,000 | 486,000 | -472,000 | -225,000 | -56,000 |
| Changes In Account Receivables | -222,000 | 61,000 | -59,000 | -10,000 | 1.1M |
| Change In Receivables | -222,000 | 61,000 | -59,000 | -10,000 | 1.1M |
| Change In Payables And Accrued Expense | 164,000 | 425,000 | -413,000 | -215,000 | -1.1M |
| Purchase Of PPE | -- | 0.00 | 0.00 | 0.00 | 7,000 |
| Net PPE Purchase And Sale | -- | 0.00 | 0.00 | 0.00 | 7,000 |
| Investing Cash Flow | -1.3M | -461,000 | -183,000 | -85,000 | -24,000 |
| Cash Flow From Continuing Investing Activities | -1.3M | -461,000 | -183,000 | -85,000 | -24,000 |
| Issuance Of Capital Stock | -- | 1.4M | -- | -- | 0.00 |
| Net Common Stock Issuance | -- | 1.4M | -- | -- | 0.00 |
| Financing Cash Flow | 14.4M | 2.4M | -- | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | 14.4M | 2.4M | -- | -- | 0.00 |
| Changes In Cash | 12.4M | 1.3M | 218,000 | -631,000 | -628,000 |
| Beginning Cash Position | 3.9M | 945,000 | 710,000 | 1.3M | 2.0M |
| End Cash Position | 16.3M | 2.4M | 945,000 | 710,000 | 1.3M |
| Free Cash Flow | -755,000 | -674,000 | -551,000 | -546,000 | -597,000 |
| Income Tax Paid Supplemental Data | 0.00 | -- | 0.00 | -- | -- |
| Interest Paid Supplemental Data | 0.00 | -- | 0.00 | -- | -- |
| Asset Impairment Charge | -- | -- | -- | -- | 1.8M |
| Common Stock Issuance | -- | 1.4M | -- | -- | 0.00 |
| Depreciation | 5,000 | 6,000 | 5,000 | 5,000 | 9,000 |
| Gain Loss On Investment Securities | 2.5M | -- | -- | -- | -- |
| Gain Loss On Sale Of PPE | -- | -- | -- | -- | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 59,000 | -595,000 | 36,000 | -47,000 | -326,000 |
| Net Income From Continuing Operations | -3.8M | -775,000 | 2.1M | -279,000 | -2.1M |
| Net Other Investing Changes | -1.2M | -461,000 | -183,000 | -85,000 | -31,000 |
| Operating Gains Losses | 2.5M | -595,000 | 36,000 | -47,000 | -326,000 |
| Other Cash Adjustment Outside Changein Cash | 1,000 | 103,000 | 17,000 | 13,000 | -26,000 |
| Proceeds From Stock Option Exercised | 1.2M | 1.0M | 0.00 | -- | 0.00 |
| Provisionand Write Offof Assets | -- | 0.00 | -- | -- | -- |
| Sale Of PPE | -- | -- | -- | -- | 0.00 |